Finally, we found that the phosphorylation at Ser9 of GSK3β, an enzyme well known for its role in the activity of BACE1 [17] and the pathogenesis of AD [18], was significantly increased in SalB-treated group (Figure 6E). The gene discussed is GSK3B; the disease is Alzheimer disease.